BACKGROUND: Hereditary lymphoedema-distichiasis (LD) is an autosomal dominant disorder that classically presents as lymphoedema of the limbs, with variable age of onset, and extra aberrant growth of eyelashes from the Meibomian gland (distichiasis). Other major reported complications include cardiac defects, cleft palate, and extradural cysts. Photophobia, exotropia, ptosis, congenital ectropion, and congenital cataracts are additional eye findings. Recently, we reported that truncating mutations in the forkhead transcription family member FOXC2 resulted in LD in two families. METHODS: The clinical findings in seven additional families with LD, including the original family described by Falls and Kertesz, were determined and mutational analyses were performed. RESULTS: Distichiasis was the most common clinical feature followed by age dependent lymphoedema. There is a wide variation of associated secondary features including tetralogy of Fallot and cleft palate. The mutational analyses identified truncating mutations in all of the families studied (two nonsense, one deletion, three insertion, and one insertion-deletion), which most likely result in haploinsufficiency of FOXC2. CONCLUSIONS: FOXC2 mutations are highly penetrant with variable expressivity which is not explicable by the pattern of mutations.
BACKGROUND:Hereditary lymphoedema-distichiasis (LD) is an autosomal dominant disorder that classically presents as lymphoedema of the limbs, with variable age of onset, and extra aberrant growth of eyelashes from the Meibomian gland (distichiasis). Other major reported complications include cardiac defects, cleft palate, and extradural cysts. Photophobia, exotropia, ptosis, congenital ectropion, and congenital cataracts are additional eye findings. Recently, we reported that truncating mutations in the forkhead transcription family member FOXC2 resulted in LD in two families. METHODS: The clinical findings in seven additional families with LD, including the original family described by Falls and Kertesz, were determined and mutational analyses were performed. RESULTS: Distichiasis was the most common clinical feature followed by age dependent lymphoedema. There is a wide variation of associated secondary features including tetralogy of Fallot and cleft palate. The mutational analyses identified truncating mutations in all of the families studied (two nonsense, one deletion, three insertion, and one insertion-deletion), which most likely result in haploinsufficiency of FOXC2. CONCLUSIONS:FOXC2 mutations are highly penetrant with variable expressivity which is not explicable by the pattern of mutations.
Authors: M J Karkkainen; R E Ferrell; E C Lawrence; M A Kimak; K L Levinson; M A McTigue; K Alitalo; D N Finegold Journal: Nat Genet Date: 2000-06 Impact factor: 38.330
Authors: D N Finegold; M A Kimak; E C Lawrence; K L Levinson; E M Cherniske; B R Pober; J W Dunlap; R E Ferrell Journal: Hum Mol Genet Date: 2001-05-15 Impact factor: 6.150
Authors: J Fang; S L Dagenais; R P Erickson; M F Arlt; M W Glynn; J L Gorski; L H Seaver; T W Glover Journal: Am J Hum Genet Date: 2000-11-08 Impact factor: 11.025
Authors: S A Stacker; C Caesar; M E Baldwin; G E Thornton; R A Williams; R Prevo; D G Jackson; S Nishikawa; H Kubo; M G Achen Journal: Nat Med Date: 2001-02 Impact factor: 53.440
Authors: T Mäkinen; L Jussila; T Veikkola; T Karpanen; M I Kettunen; K J Pulkkanen; R Kauppinen; D G Jackson; H Kubo; S Nishikawa; S Ylä-Herttuala; K Alitalo Journal: Nat Med Date: 2001-02 Impact factor: 53.440
Authors: Matthew G Butler; Susan L Dagenais; José L Garcia-Perez; Pascal Brouillard; Miikka Vikkula; Peter Strouse; Jeffrey W Innis; Thomas W Glover Journal: Am J Med Genet A Date: 2012-03-09 Impact factor: 2.802
Authors: Carolyn Sholto-Douglas-Vernon; Rachel Bell; Glen Brice; Sahar Mansour; Mansoor Sarfarazi; Anne H Child; Alberto Smith; Russell Mellor; Kevin Burnand; Peter Mortimer; Steve Jeffery Journal: Hum Genet Date: 2005-05-20 Impact factor: 4.132
Authors: G Brice; S Mansour; R Bell; J R O Collin; A H Child; A F Brady; M Sarfarazi; K G Burnand; S Jeffery; P Mortimer; V A Murday Journal: J Med Genet Date: 2002-07 Impact factor: 6.318
Authors: Marlys H Witte; Michael T Dellinger; Cristobal M Papendieck; Francesco Boccardo Journal: Clin Exp Metastasis Date: 2012-07-15 Impact factor: 5.150